Introduction

Hyperpolarized 13C metabolic MR using 13C-bicarbonate can be used to determine preclinically pH in vivo [14]. pH serves as a key parameter in many disorders [5], with cancer being among the most commonly investigated [68]. Bicarbonate is a major pH buffer in living systems (blood concentration 25 mmol/L), keeping pH within tight boundaries (pH = 7.35–7.45). Bicarbonate binds with excess protons (decreased pH in vivo) forming carbonic acid. Upon dissociation into water and CO2, the latter can be exhaled and the pH returns to physiological values. The reverse occurs when protons are lacking and the pH increases above blood pH. Here, CO2 and water form carbonic acid, and a proton is released during the conversion of carbonic acid into bicarbonate. In vivo, these reactions are catalyzed by the enzyme family of carbonic anhydrases, with up to 106 reactions per second, which leads to a nearly instantaneous pH-dependent equilibrium between bicarbonate and CO2 concentration. According to Henderson–Hasselbalch, the concentrations of both bicarbonate and CO2 can be related directly to the pH (see Eq. 1), where pKa is the dissociation constant and assumed to take on the value of 6.17 in vivo [9]:

$${\text{pH}} = {\text{pKa}} + \log_{10} \frac{{\left[ {{\text{HCO}}_{3}^{ - } } \right]}}{{\left[ {{\text{CO}}_{2} } \right]}}$$
(1)

Via dissolution dynamic nuclear polarization (DNP) a signal enhancement of carbon-13 atoms by a factor of >10,000 can be achieved [10]. However, only a few publications provide detail on experimental factors (i.e. buffer capacity, viscosity, pH, magnetic field strength, temperature) that directly affect 13C-bicarbonate and 13CO2 T1 relaxation times, the achievable signal, and thus pH-mapping quality for in vitro or in vivo applications. Neglecting these influences may lead to increased signal attenuation in pH-imaging experiments, where 13CO2 needs to be produced from 13C-bicarbonate and subsequently imaged. Since at normal tissue pH, CO2 concentration and the corresponding signal is at least an order of magnitude smaller than the 13C-bicarbonate signal, 13CO2 imaging is only possible using an experimental setup, where 13C-bicarbonate exhibits maximum SNR and T1 values. Thus, signal conservation was the primary goal while preparing and performing experiments.

In this work, it is shown that optimizing multiple chemical, biological, and physical parameters at sample preparation and dissolution steps has a large impact on SNR and T1 decay, illustrating the prohibitive constraints for pH mapping. To achieve sufficient SNR, a formulation for hyperpolarizing 13C-bicarbonate was developed and extensively analyzed in terms of maximizing solubility, radical concentration, gadolinium concentration, and optimizing solid- and liquid-state polarization buildup and decay parameters. The results led to higher concentrations and improved SNR and T1 for the hyperpolarized compound. Still, the signal origin (intra- or extracellular) of the measured pH, when using hyperpolarized 13C-bicarbonate, is undetermined. It could be separated by their respective apparent diffusion coefficients (ADCs), which are different for intra- and extracellular space [11, 12]. Prior to using this approach, however, SNR and T1 need to be sufficient for a cell environment. To this end, a dissolved 13C-bicarbonate sample was added to an in vitro solution of MCF-7 spheroid cells to investigate its influence on SNR and T1 in different environments (pure dissolution buffer, culture medium, and highly concentrated MCF-7 cell spheroid solution) for field strengths of 1, 3, and 14 T. Additionally, different pH levels were tested and controlled by electrode pH measurements. Finally, in vivo perfusion experiments were performed, showing the time-dependent distribution of the hyperpolarized 13C-bicarbonate in different healthy rat organs (heart, liver, kidney, and bowel).

Materials and methods

Synthesis and preparation of 13C-Cs-bicarbonate for dissolution

13C-sodium bicarbonate was initially tested, but exhibited very limited solubility, thus cesium was chosen (better solubility due to larger counter ion, lower grid enthalpy). For the synthesis, 1.3 g cesium hydroxide monohydrate (Sigma Aldrich, CAS: 35103-79-8) was mixed with 20 mL H2O to a concentration of 0.389 mol/L and stirred under a 13CO2 (Sigma Aldrich/Euriso-top) atmosphere, monitoring the pH value continuously until a value of ~7 was established, marking the completion of the following reaction:

$$2 {\text{CsOH}} +^{13}\!\!{\text{CO}}_{2} \to {\text{Cs}}_{2}^{13}\!{\text{CO}}_{3} + {\text{H}}_{2} {\text{O}}$$
(2)
$${\text{Cs}}_{2}^{13}\!{\text{CO}}_{3} + ^{13}\!\!{\text{CO}}_{2} + {\text{H}}_{ 2} {\text{O}} \to 2{\text{CsH}}^{13}\!{\text{CO}}_{3}$$
(3)

The 13C-Cs-bicarbonate solution was subsequently lyophilized; approximately 1.3 g 13C-Cs-bicarbonate was obtained.

Solid-state polarization tests revealed glassing performance for every agent at 1.4 K. For the final 13C-Cs-bicarbonate preparation, 1.3 g of an 80/20 %m glycerol/D2O mixture was combined with 1.3 g 13C-Cs-bicarbonate powder using an ultrasonic bath and a heat gun at 60 °C, mixed for 2 h for total dissolution, leading to a clear glass when frozen at 1.4 K. The final 13C-Cs-bicarbonate concentration was 6 mol/L. The compound exhibiting the best polarization properties was subsequently analyzed in terms of dissolution parameters, especially T1 and polarization level, for maximum SNR. Varying concentrations of buffers, including TRIS and PBS based on H2O and D2O, were tested at different pH levels for their impact on the pH and T1 of the final hyperpolarized 13C-Cs-bicarbonate solution.

MCF-7 cell spheroid preparation

The human breast cancer cell line MCF-7 was maintained as a monolayer culture in Dulbecco’s modified Eagle’s medium, supplemented with 5 % fetal calf serum (culture medium). To obtain three-dimensional aggregates (spheroids), cells were transferred to spinner flasks and were incubated by gently stirring for up to 6 days at 37 °C and 10 % CO2. For cell count, spheroids were treated with a hypotonic buffer (20 mM HEPES, 1.0 mM MgCl2, 0.5 mM CaCl2, pH 7.2) followed by a 5 % benzalkonium chloride solution in glacial acetic acid to obtain a nuclei suspension for electronic counting (Casy, Schärfe, Germany). Immediately before the 13C-NMR measurements, a spheroid suspension containing 50 × 106 cells was centrifuged (100×g) and resuspended in 1 mL of cell medium.

Polarization level detection and T1 estimation

Polarization levels were determined directly after dissolution using a Bruker Minispec mq40 NMR analyzer (Bruker Optik, Ettlingen, Germany) with a fourfold-repeated 20° flip-angle excitation (FID). Thermal polarization was determined using 12-fold Carr–Purcell–Meiboom–Gill (CPMG) pulse trains. T1 times were measured at field strengths of 1, 3, and 14 T. At 1 T the Bruker Minispec with a 10° flip angle excitation and TR of 10 s was used. The 3 T T1 measurements were performed using a 3 T GE HDx v23 (GE Healthcare, Milwaukee, WI, USA) with a 13C TR solenoid coil (in-house design) with an excitation flip angle of 10° and TR of 1 s. 14 T measurements were performed using a 600 MHz Bruker spectrometer with Avance III console (Bruker BioSpin, Rheinstetten, Germany) with an excitation flip angle of 10° and TR of 1 s.

All experimental data were corrected for the depletion of the hyperpolarized signal during acquisition and quantified with Matlab (MathWorks, Natick, MA, USA). Spectral data at 3 T were quantified using the AMARES algorithm (jMRUI 4.0) [13]. At 14 T, spectral data were apodized with 15 Hz and peaks integrated with MestReNova (mestrelab Research, Santiago de Compostela, Spain). Hyperpolarized 13C-bicarbonate was dissolved and measured in a final concentration of 25 mmol/L. For 1 T measurements, the pure hyperpolarized dissolution was measured. For the 3 and 14 T measurements, the hyperpolarized liquid was added to 1 mL culture medium and 1 mL spheroid suspension, respectively.

In vivo 13C-bicarbonate imaging

In vivo 13C-bicarbonate imaging was performed on healthy Lewis rats using a custom-designed spectral–spatial excitation pulse (excitation bandwidth 148 Hz, flip angle 10° at 13C-bicarbonate resonance frequency) and spiral trajectory (resolution 16 × 16, FOV = 8 cm, slice thickness = 10 mm, TR = 2 s). Five milliliters per kilogram rat weight of a 200 mmol/L 13C-bicarbonate solution was injected through the tail vein and data acquisition started immediately.

Results

Optimizing the hyperpolarization formulation

Although the maximum solubility of bicarbonate in glycerol increases with temperature, for bicarbonate, increasing temperature leads to an increased conversion to carbonate as follows:

$$2{\text{NaHCO}}_{3} \to {\text{CO}}_{2} + {\text{H}}_{2} {\text{O}} + {\text{Na}}_{2} {\text{CO}}_{3}$$
(4)

This results in very low polarization levels (≤5 %) for preparation at temperatures ≥80 °C, owing to the loss of bicarbonate; too low temperatures prevent dissolution due to the high viscosity of glycerol. The optimum temperature was determined to be 60 °C; an increased D2O/glycerol ratio led to a decreased viscosity (allowing lower temperatures). Decreasing the amount of glycerol from 80 to 50 % led to decreased liquid-state polarization from 19–21 to 10–11 %, owing to the better glassing properties of glycerol.

Different OXO63 radical concentrations (14–69 mmol/L) were investigated, with the radical primarily affecting the T1 relaxation time (increases relaxivity by 0.01 mmol/L/s). The hyperpolarized solid state signal showed limited maximum values for a concentration of ≥42 mmol/L. At 14 mmol/L, the solid-state buildup was not yet complete (< 95 %) after 2 h of polarization. The liquid–state signal collapsed with OXO at ≥ 42 mmol/L. The optimal radical concentration was found to be approximately 25 mmol/L, which exhibited a desirable solid-state level, an acceptable buildup time (90 min) for >99 % solid-state polarization, and a desirable liquid-state signal after dissolution. All polarization experiments were performed with an OXO concentration of 25 mmol/L.

Different gadolinium concentrations (ranging from 0 to 3.5 mmol/L) were tested in relation to T1 (see Fig. 1a), measured at 1 T. Gd increases the maximum achievable solid-state signal, mainly because increasing its concentration leads to higher polarization levels. Gd decreases the T1 of the electrons involved in the polarization process, thus at 100  mW irradiation (power-saturated regime) the polarization becomes more efficient [14]. Higher Gd concentrations also affected CPMG acquisitions, increasing the error of the estimated polarization. Moreover, T1 decreases with increasing Gd concentration [15]. An optimal Gd concentration was thus found at 0.5 mmol/L, (tradeoff between increased polarization level and reduced T1 relaxation time).

Fig. 1
figure 1

a Influence of Gd concentration (horizontal axis) on T1 of 13C-Cs-bicarbonate decay after dissolution in D2O (vertical axis). Error bars indicate 95 % confidence boundaries of the mono-exponential fit. T1 decreases with increasing Gd concentration. Two dissolution experiments were performed for each Gd concentration to ensure reproducibility; b intravascular 13C-bicarbonate signal intensities for different in vivo cross sections. The vertical axis shows the signal intensities, normalized to the highest intensity at t = 0 s. The horizontal axis shows time after injection in seconds. After 6 s, 85 % of the hyperpolarized signal is decayed (dotted line), comparable to a T1 of approximately 1 s. In this region, parts of the injection bolus pass and the intravascular signal diffuses into extravascular and intracellular regions. The remaining 15 % signal decays with a T1 of 10 s, which is the part that may be used for pH detection; c in vivo T1-decay of 13C-bicarbonate, measured for different organ cross sections in a healthy rat. Error was calculated using 95 % confidence boundaries of the mono-exponential fit

Optimal polarization results were achieved for 25 mmol/L radical (OXO) and 0.5 mmol/L Gd (Dotarem). A 200 µL volume of the sample was then polarized for 90 min in a HyperSense DNP polarizer (Oxford Instruments, Abingdon, UK). The hyperpolarized sample was subsequently dissolved with a heated dissolution agent (PBS) with EDTA added (0.1 g/L) at 168 °C. The final dissolved solution had a physiological pH, osmolarity, and temperature. The pH was controlled externally by a pH electrode. The final polarization level was approximately 19 %.

Optimizing dissolution parameters

To increase T1, a D2O-based, pH-buffered dissolution agent was chosen for in vivo experiments, keeping the pH and osmolality at physiological levels. The bicarbonate itself acts as a pH buffer, though the pure Cs-bicarbonate dissolution showed pH values of 8.2–8.4, so the final pH needed to be balanced with the dissolution agent buffer to preserve 13C-bicarbonate (at lower pH 13CO2 gets released during the turbulent dissolution process). Furthermore, depending on the buffer used, the temperature of the dissolution liquid (heated to 168 °C during dissolution) might affect the pKa and thus the pH. The pH change of the phosphate buffer [16] was thus described as:

$${\text{pH}} = {\text{pH}}_{\text{start}} - 0.0028 \times\Delta {\text{temp}}$$
(5)

For simulation, \({\text{pH}}_{\text{start}} = 7.0\) is assumed. Signal loss was calculated by transforming Eq. (1) to

$${\text{sig}}_{\text{loss}} = \frac{100}{{{\text{sig}}_{{{\text{CO}}_{2} }} + 10^{{{\text{pH}} - {\text{pKa}}}} }}$$
(6)

with \(10^{{{\text{pH}} - {\text{pKa}}}} = {\text{sig}}_{\text{BiC}} = 10{\text{ signal of}}\;^{13} {\text{C}} - {\text{bicarbonate}}\); \({\text{sig}}_{{{\text{CO}}_{2} }} = 1 = {\text{signal of}}\,^{13} {\text{CO}}_{2}\); \({\text{sig}}\_{\text{loss}} = {\text{percentage of}} \,^{13} {\text{CO}}_{2} \,{\text{contributing to the overall signal}}\); and \({\text{pKa}} = 6.2\), as reported in vivo [2, 9]. When the pH decreases, increasing the temperature during the dissolution process from room temperature to 168 °C leads to a decrease in pH. Hence, the contribution of 13CO2 to the overall signal becomes larger. Assuming that all 13CO2 buildup due to the pH decrease is removed, the signal loss increases from 13.7 % at room temperature to 32.4 % at dissolution temperature. This loss is treated as a full removal of 13CO2 after equilibrium is established. This assumption is simplified owing to the fact that the buildup of the equilibrium is a permanent and dynamic process. In addition, the release of CO2 is dynamic and, moreover, the dynamics change during the dissolution process. Regardless of the assumptions made, there is a significant impact from the temperature of the dissolution agent, which was taken into account during its preparation.

In vitro application with MCF-7 tumor spheroids

T1 (at 1, 3 and 14 T) and SNR of the hyperpolarized 13C-bicarbonate signal of the culture medium with and without MCF-7 tumor spheroids were investigated (see Table 1) using 10° excitation and subsequent FID readout. The pH values were controlled by a common glass electrode. At 1 T, the T1 of 13C-bicarbonate, dissolved in a D2O-based phosphate buffer, showed a decrease with decreasing pH or increased phosphate concentration. At 3 T, the T1 of 13C-bicarbonate and 13CO2 were measured with and without added MCF-7 cell spheroids. 13CO2 showed similar T1 values, compared to 13C-bicarbonate for measurements with added MCF-7 cell spheroids. The T1 of 13C-bicarbonate was only increased in the culture medium; it decreased when cells were added to the solution. This T1 decrease was not detectable for 13CO2 where T1 did not decrease significantly following spheroid addition. The bicarbonate’s T1 is decreased by fast exchange with multiple weak binding sides of macromolecules in the suspension. After the T1 experiments, the pH of the spheroid suspension was controlled with a pH electrode and showed a decreasing pH with time. This is an indication of ongoing cell metabolism. During this time, the highly concentrated cell solution acidifies its environment. The measurements at highest buffer concentration and lowest pH (far right column, Table 1) showed a significant drop in T1 for both bicarbonate and CO2, and no CO2 buildup was observed. These results show the clear influence of field strength on bicarbonate T1, as well as the sample’s viscosity on the physical side. On the chemical side, increasing pH and buffer capacity leads to a decreased T1.

Table 1 T1 times and errors for 13C-bicarbonate and 13CO2 in culture medium (orange), cell spheroid suspension (green), and pure dissolution (blue) for 1, 3, and 14 T

In vivo imaging on healthy Lewis rats

The hyperpolarized 13C-bicarbonate solution was injected via a tail vein, and data acquisition began immediately after injection. The bicarbonate kinetics were acquired with Δt = 4 s for four cross sections: heart, liver, kidney, and bowel (see Fig. 2).

Fig. 2
figure 2

13C-bicarbonate signal after a tail-vein injection (21 s after dissolution) of approximately 1 mL hyperpolarized solution at different times for different cross sections. Positions of organs are marked with white arrows in the t = 4 s series. A 10° FA excitation was used, with frequency selective spectral spatial pulses, applied on resonant at the 13C-bicarbonate resonance frequency, and subsequent spiral trajectory readout. Cross section thickness = 10 mm, FOV = 8 cm × 8 cm. Signals from the heart and liver were normalized to maximum peak intensity. Signals for kidney and bowel were normalized to a fixed value for better visibility of bicarbonate in the peripheral tissue

The heart cross section, measured directly after injection (t = 0 s), showed a distribution of 13C-bicarbonate only in the right ventricle, as expected, where it arrived after injection and spread to the left ventricle with increasing time. Liver, kidney, and bowel sections showed 13C-bicarbonate concentration predominantly in the vena cava. The liver sections only showed 13C-bicarbonate in the vena cava. Although the liver is well perfused, no bicarbonate signal became visible in the surrounding tissue. This might be owing to the presence of paramagnetic centers to which the bicarbonate can bind, which reduces T1. The kidney section showed maximal 13C-bicarbonate concentration directly after injection. This reflects the high perfusion of the kidneys. Bowel tissue is well perfused at t = 0 s and the signal decays with increasing time. The decay of the 13C-bicarbonate signal can be attributed to multiple factors; the hyperpolarized signal completely decays in vivo with a T1 of approximately 10 s. In addition, the hyperpolarized signal is consumed for every excitation. Meanwhile, the bicarbonate is filtered by the kidneys, converted by the liver, constantly converted to CO2 in the blood and tissue, and subsequently exhaled.

In vivo bicarbonate, CO2 and the resulting pH map for exemplary cross sections through the bowel and hind legs of a healthy rat are depicted in Fig. 3. The pH is only calculated in image areas, where both bicarbonate and CO2 images exhibit signal intensity about the mean noise level, i.e. in the bowel region, the central area around the blood vessel.

Fig. 3
figure 3

In vivo (from left to right) 13C-bicarbonate, 13CO2, and pH images of a healthy Lewis rat, depicting bowel (top row) and leg region. pH was calculated in ROI above the mean noise level only, exhibiting strong signals in the central area around the blood vessel and the intestines

Determination of 13C-bicarbonate T1 in vivo

The longitudinal signal evolution of the hyperpolarized 13C-bicarbonate was investigated with the aim of identifying a suitable time to begin image acquisition. Determination of this T1 decay was performed by using a voxel of highest intensity at t = 0 s within the acquired intensity map (see Fig. 2), which was found to be mainly intravascular because of the bolus. After 13C-bicarbonate injection via the tail vein, a rapid decay of the hyperpolarized signal of 13C-bicarbonate could be observed within 6 s (see Fig. 1b). This initial, rapid decay is dominated by the fading of the bolus signal and most likely due to perfusion into smaller blood vessels. Additional contributions to signal decay are due to the diffusion and transport in the peripheral tissue, kidney filtration, and CO2 conversion and exhalation. From this data, 13C-bicarbonate perfusion equilibrated at around 6 s, reaching a steady state, after which in vivo pH measurements could be performed. After the injection bolus has passed, the signal decayed with a T1 of around 10 s for all cross sections (see Fig. 1c). These values are comparable with in vivo values previously published [2].

Discussion

In this work, the process of hyperpolarization of 13C-Cs-bicarbonate was investigated quantitatively, in terms of preparation and dissolution parameters. Because of the sensitivity of 13C-bicarbonate to temperature and pH, these parameters must be controlled carefully during experiments to achieve a sufficiently high concentration and T1 for a maximum SNR. T1 analysis for the hyperpolarized compound showed sufficiently long decay times for all investigated field strengths, and the effects of pH, buffer capacity, and viscosity on 13C-bicarbonate T1 were analyzed. A lowered pH led to a reduced T1, which should be taken into account when investigating conditions with symptomatically low pH, as in cases of tumor acidification or inflammatory diseases. In addition, low pH inhibits the enzymatic activity of carbonic anhydrase, leading to a slower establishment of the pH-dependent bicarbonate to CO2 ratio at more acidic pH values. It was shown that the T1 and SNR were high enough to prompt further investigations, even at higher field strengths, i.e., applying the diffusion-based approach for intra and extracellular signal determination measured with MCF-7 cell spheroids, which has been shown to work at 14 T with MCF-7 cell spheroids [11] and 4.7 T in animals [12] for hyperpolarized [1-13C]-pyruvate, and may be successfully applied to 13C-bicarbonate. This allows the determination of the signal contribution of intracellular signals, and hence the impact on hyperpolarized 13C-bicarbonate pH measurements. Moreover, the intravascular in vivo T1 values of 13C-bicarbonate are sufficiently long in different organs, and are comparable to previously published values [2]. However, the distribution of bicarbonate is dependent on the target organ, which makes it difficult to estimate an ideal measurement time frame and needs to be investigated in each case. In general, bolus detection should be avoided to minimize errors, which arise from the variation in perfusion between organs. Because of the very low 13CO2 signal intensity, multiple excitations and acquisition of 13CO2 kinetics were not feasible. Therefore, imaging is limited to acquisition schemes using configurations such as a 90° flip-angle excitation for 13CO2. To determine spatial pH, a high SNR of both the 13C-bicarbonate and 13CO2 signals is needed. Hence, it is crucial to determine the ideal time point of acquisition, where the hyperpolarized 13C-bicarbonate is diffused to the targeted tissue and the signal has not decayed. Most of the 13C-bicarbonate signal is lost within the first few seconds as the bolus is passed, leading to a residual signal of only 15 %. The remaining signal can be assumed to be non-perfusion-dominated, leading to T1 times of around 10 s, which are comparable with values reported previously [2]. To lose such a high amount of signal within the first seconds raises the question of whether a systemic injection through the tail vein might not be optimal for pH mapping, since breathing and kidney filtration effectively removes the hyperpolarization-labeled substances. Thus, injection could be performed in a vein or artery closer to the targeted organ, which should reduce the initial signal loss. Hence, more time would be allotted for diffusion through the tissues and the buildup of the 13CO2 pool required for acquisition.

Conclusion

The preservation of hyperpolarized signals is crucial for the application of hyperpolarized 13C-bicarbonate in dissolution-DNP experiments. SNR is heavily dependent on parameters involved in both sample preparation and experimental procedure. Carefully tuning these parameters helps avoid pitfalls in signal depletion, resulting in sufficient, though not excellent, SNR and T1 for in vivo 13C-bicarbonate and pH mapping.